Tissue Engineering, Stem Cells, Cloning, and Parthenogenesis: New Paradigms for Therapy

Overview

Journal J Exp Clin Assist Reprod

Specialty Medical Ethics

Date 2004 Dec 14

PMID 15588286

Citations 10

Authors

Jason Hipp

Anthony Atala

Affiliations

Soon will be listed here.

Abstract

: BACKGROUND: Patients suffering from diseased and injured organs may be treated with transplanted organs. However, there is a severe shortage of donor organs which is worsening yearly due to the aging population. Scientists in the field of tissue engineering apply the principles of cell transplantation, materials science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. Both therapeutic cloning (nucleus from a donor cell is transferred into an enucleated oocyte), and parthenogenesis (oocyte is activated and stimulated to divide), permit extraction of pluripotent embryonic stem cells, and offer a potentially limitless source of cells for tissue engineering applications. The stem cell field is also advancing rapidly, opening new options for therapy. The present article reviews recent progress in tissue engineering and describes applications of these new technologies that may offer novel therapies for patients with end-stage organ failure.

Citing Articles

Extracellular Vesicles in Musculoskeletal Regeneration: Modulating the Therapy of the Future.

Abreu H, Canciani E, Raineri D, Cappellano G, Rimondini L, Chiocchetti A Cells. 2022; 11(1).

PMID: 35011605 PMC: 8750529. DOI: 10.3390/cells11010043.

Electrofusion Stimulation Is an Independent Factor of Chromosome Abnormality in Mice Oocytes Reconstructed Spindle Transfer.

Wang W, Shao S, Chen W, Wang W, Chuai Y, Li Y Front Endocrinol (Lausanne). 2021; 12:705837.

PMID: 34413830 PMC: 8370092. DOI: 10.3389/fendo.2021.705837.

Healing of Artificially Created Gap Non-union Using Autologous Cultured Osteoblasts Impregnated Over Three-Dimensional Biodegradable Scaffold: An Experimental Study (Rabbit).

Singh V, Singh M, Belbase R, Rastogi A Indian J Orthop. 2021; 55(Suppl 2):460-465.

PMID: 34306561 PMC: 8275701. DOI: 10.1007/s43465-020-00288-z.

An improved transplantation strategy for mouse mesenchymal stem cells in an acute myocardial infarction model.

Jin J, Zhao Y, Tan X, Guo C, Yang Z, Miao D PLoS One. 2011; 6(6):e21005.

PMID: 21698117 PMC: 3117862. DOI: 10.1371/journal.pone.0021005.

In vivo and in vitro differentiation of uniparental embryonic stem cells into hematopoietic and neural cell types.

Eckardt S, Dinger T, Kurosaka S, Leu N, Muller A, McLaughlin K Organogenesis. 2009; 4(1):33-41.

PMID: 19279713 PMC: 2634177. DOI: 10.4161/org.6123.

References

Sasaki H, Jones P, Chaillet J, Ferguson-Smith A, Barton S, Reik W . Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev. 1992; 6(10):1843-56. DOI: 10.1101/gad.6.10.1843. View

Hochedlinger K, Jaenisch R . Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med. 2003; 349(3):275-86. DOI: 10.1056/NEJMra035397. View

Fischer Lindahl K, Hermel E, Loveland B, Wang C . Maternally transmitted antigen of mice: a model transplantation antigen. Annu Rev Immunol. 1991; 9:351-72. DOI: 10.1146/annurev.iy.09.040191.002031. View

Steinborn R, Schinogl P, Zakhartchenko V, Achmann R, Schernthaner W, Stojkovic M . Mitochondrial DNA heteroplasmy in cloned cattle produced by fetal and adult cell cloning. Nat Genet. 2000; 25(3):255-7. DOI: 10.1038/77000. View

Wilmut I, Schnieke A, McWhir J, Kind A, Campbell K . Viable offspring derived from fetal and adult mammalian cells. Nature. 1997; 385(6619):810-3. DOI: 10.1038/385810a0. View

Lanza R, Cibelli J, WEST M . Prospects for the use of nuclear transfer in human transplantation. Nat Biotechnol. 1999; 17(12):1171-4. DOI: 10.1038/70709. View

Hiendleder S, Schmutz S, Erhardt G, Green R, Plante Y . Transmitochondrial differences and varying levels of heteroplasmy in nuclear transfer cloned cattle. Mol Reprod Dev. 1999; 54(1):24-31. DOI: 10.1002/(SICI)1098-2795(199909)54:1<24::AID-MRD4>3.0.CO;2-S. View

MacKay S, Funke A, Buffington D, Humes H . Tissue engineering of a bioartificial renal tubule. ASAIO J. 1998; 44(3):179-83. DOI: 10.1097/00002480-199805000-00011. View

Hwang W, Ryu Y, Park J, Park E, Lee E, Koo J . RETRACTED: Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science. 2004; 303(5664):1669-74. DOI: 10.1126/science.1094515. View

10.

Bortvin A, Eggan K, Skaletsky H, Akutsu H, Berry D, Yanagimachi R . Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development. 2003; 130(8):1673-80. DOI: 10.1242/dev.00366. View

11.

Baguisi A, Behboodi E, Melican D, Pollock J, Destrempes M, Cammuso C . Production of goats by somatic cell nuclear transfer. Nat Biotechnol. 1999; 17(5):456-61. DOI: 10.1038/8632. View

12.

Cibelli J, Stice S, Golueke P, KANE J, Jerry J, Blackwell C . Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science. 1998; 280(5367):1256-8. DOI: 10.1126/science.280.5367.1256. View

13.

Tamashiro K, Wakayama T, Akutsu H, Yamazaki Y, Lachey J, Wortman M . Cloned mice have an obese phenotype not transmitted to their offspring. Nat Med. 2002; 8(3):262-7. DOI: 10.1038/nm0302-262. View

14.

Strain L, Warner J, Johnston T, Bonthron D . A human parthenogenetic chimaera. Nat Genet. 1995; 11(2):164-9. DOI: 10.1038/ng1095-164. View

15.

Cibelli J, Campbell K, Seidel G, West M, Lanza R . The health profile of cloned animals. Nat Biotechnol. 2001; 20(1):13-4. DOI: 10.1038/nbt0102-13. View

16.

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

17.

Keefer C, Keyston R, Lazaris A, Bhatia B, Begin I, Bilodeau A . Production of cloned goats after nuclear transfer using adult somatic cells. Biol Reprod. 2001; 66(1):199-203. DOI: 10.1095/biolreprod66.1.199. View

18.

Plachot M, Mandelbaum J, de Grouchy J . [In vitro parthenogenesis in the human species]. Ann Genet. 1984; 27(3):158-61. View

19.

Aebischer P, Ip T, Panol G, Galletti P . The bioartificial kidney: progress towards an ultrafiltration device with renal epithelial cells processing. Life Support Syst. 1987; 5(2):159-68. View

20.

Rackley R, Bandyopadhyay S, Shin M, Appell R . Immunoregulatory potential of urothelium: characterization of NF-kappaB signal transduction. J Urol. 1999; 162(5):1812-6. DOI: 10.1016/s0022-5347(05)68243-2. View